about iatroX
Founder
Why iatroX exists
Before medicine, I built and scaled digital products to millions of users — learning how to ship fast, iterate with discipline, and think in systems. That engineering foundation sits behind every part of iatroX today.
I have dyspraxia and dyslexia. For most of my education that meant fighting the system rather than using it — information scattered across dozens of tabs, dense guideline documents that punish non-linear readers, and search interfaces that return noise when you need signal. Every unnecessary retrieval step burns cognitive power that could be spent on clinical reasoning, pattern recognition, or simply being present with a patient. That cost isn't abstract to me; I feel it every working day.
Qualifying at King's College London and completing GP training in London, I saw that this isn't just a neurodivergent problem — it's a universal one. Cognitive overload at the point of care affects every clinician: the time pressure, the knowledge fragmentation, the friction of searching five different sources to confirm a single prescribing decision. The research in cognitive science and information retrieval is clear — working memory is finite, and every avoidable retrieval step degrades the quality of the decisions that follow. Yet most clinical tools are still built as if attention were unlimited.
iatroX is the tool I needed to exist: a single, regulated platform that eliminates retrieval friction, surfaces authoritative guidance in seconds, and helps clinicians and students retain what they learn — grounded in cognitive science rather than intuition. If it preserves even a fraction of the cognitive power that clinicians currently waste on searching, navigating, and re-finding — it will have been worth building.
What iatroX is
iatroX is a UKCA-marked, MHRA-registered Class I medical device. It brings together three capabilities in one platform: an AI clinical reference tool grounded in UK guidelines and international sources, an adaptive examination engine covering UK, US, Canadian and Australian boards and specialist diplomas, and integrated CPD tracking for UK clinicians.
The learning engine is built on peer-reviewed methods: active recall, spaced repetition, and adaptive sequencing. These are not buzzwords — they are the learning mechanisms with the strongest evidence base for long-term retention, and iatroX applies them automatically so clinicians and students don't just find information, they retain it.
Whether you are a GP, a specialist trainee preparing for a diploma, an international medical graduate adapting to a new system, or a pharmacy student sitting the GPhC CRA — iatroX is designed to close the gap between knowledge and action.
iatroX is built under a disciplined, regulatory-grade development process: UKCA-marked and MHRA-registered as a Class I medical device, with published technical methodology, a peer-reviewed arXiv research paper, and established data partnerships. Clinical content is mapped to current UK guidance and reviewed against the associated exam blueprints.
Where iatroX is going
The goal is broad adoption across healthcare systems worldwide — to make evidence-based guidance second nature at the point of care rather than a time-consuming barrier. The roadmap extends from UK specialist diplomas and the GPhC pharmacy vertical into deeper clinical reference, CPD, and institutional deployments for NHS Trusts, deaneries and medical schools.